MANAR HANNA: Open Payments
NPI 1588625859 · EATONTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,597 in 118 payments from 22 companies in 2025. Trend: 2023 $3,819 · 2024 $3,658 · 2025 $2,597
Food & beverage: $2,587Education: $10
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 32 | $839 |
| ABBVIE INC. | 26 | $380 |
| Amgen Inc. | 8 | $334 |
| Kowa Pharmaceuticals America, Inc. | 11 | $148 |
| Janssen Biotech, Inc. | 1 | $134 |
| GlaxoSmithKline, LLC. | 8 | $129 |
| Intra-Sana Laboratories | 1 | $116 |
| Lilly USA, LLC | 5 | $78 |
| Novo Nordisk Inc | 3 | $52 |
| Exact Sciences Corporation | 2 | $45 |
Products named: FASENRA, VRAYLAR, OTEZLA, BREZTRI, AIRSUPRA, ZORYVE, TREMFYA, UPLIZNA.
Industry payments across NJ — which companies pay providers there.
